including therapies, diagnostics, and vaccines, including for coccidioidomycosis. (b) Authorization of appropriations There are authorized to be appropriated to the Biodefense Medical Countermeasure Development Fund established under section 319L(d) of the Public Health Service Act (42 U.S.C. 247d–7e(d)) to carry out subsection (a) $10,000,000 for each of fiscal years 2019 through 2024, to remain available until expended. 9. Blockchain pilot program for hospital data security for coccidioidomycosis research Part A of title IV of the Public Health Service Act ( 42 U.S.C. 281 et seq.) is amended by adding at the end the following new section: 404O. Blockchain pilot program for hospital data security for coccidioidomycosis research (a) In general The Director of NIH shall carry out a pilot program to conduct, support, and facilitate auditable research on coccidioidomycosis (commonly referred to as Valley Fever ). In carrying out such program, the Director shall— (1) award a grant to an eligible entity to install a blockchain on the servers of, or otherwise provide blockchain services to, the National Institutes of Health, and provide support with respect to such a blockchain, which shall contain public, unalterable data which includes every query made through the procedure established under subsection (c), as well as the identity of the individual who asked such a question, without disclosing the results of such queries